Abstract
Benign hereditary chorea (BHC) is an autosomaldominant disorder of early onset characterized by a slowly progressing or nonprogressing chorea, without cognitive decline or other progressive neurologic dysfunction, but also by the existence of heterogeneity of the clinical presentation within and among families. The genetic cause of BHC is the presence of either point mutations or deletions in the thyroid transcription factor 1 gene (TITF1). We studied a Portuguese BHC family composed of two probands: a mother and her only son. The patients were identified in a neurology out-patient clinic showing mainly involuntary choreiform movements since childhood, myoclonic jerks, falls, and dysarthria. We performed magnetic resonance imaging (MRI), electroencephalogram (EEG), nerve conduction studies, thyroid ultrasound scan, biochemical thyroid tests, and electrocardiogram (ECG). We excluded Huntington disease by appropriate genetic testing and sequenced the entire TITF1 gene for both patients. The patients showed MRI alterations: (1) in the mother, abnormal hyperintense pallida and cortical cerebral/cerebellar atrophy; and (2) in the son, small hyperintense foci in the cerebellum and subtle enlargement of the fourth ventricle. Sequence analysis of the TITF1 gene in these patients revealed the presence of a heterozygous C > T substitution at nucleotide 745, leading to the replacement of a glutamine at position 249 for a premature stop codon. A previously undescribed nonsense mutation in the TITF1 gene was identified as being the genetic cause of BHC in this family.
Similar content being viewed by others
References
Haerer AF, Currier RD, Jackson JF (1967) Hereditary nonprogressive chorea of early onset. N Engl J Med 276:1220–1224
Schrag A, Quinn NP, Bhatia KP, Marsden CD (2000) Benign hereditary chorea—entity or syndrome? Mov Disord 15:280–288
de Vries BBA, Arts WFM, Breedveld GJ, Hoogeboom JJM, Niermeijer MF, Heutink P (2000) Benign hereditary chorea of early onset maps to chromosome 14q. Am J Hum Genet 66:136–142
Breedveld GJ, van Dongen JWF, Danesino C, Guala A, Percy AK, Dure LS, Harper P, Lazarou LP, van der Linde H, Joosse M, Grüters A, MacDonald ME, de Vries BBA, Arts WFM, Oostra BA, Krude H, Heutink P (2002) Mutations in TITF-1 are associated with benign hereditary chorea. Hum Mol Genet 11:971–979
Guazzi S, Price M, De Felice M, Damante G, Mattei G, Di Lauro R (1990) Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 9:3631–3639
Harvey RP (1996) NK-2 homeobox genes and heart development. Dev Biol 178:203–216
Krude H, Schütz B, Bierbermann H, von Moers A, Schnabel D, Neitzel H, Tönnies H, Weise D, Lafferty A, Schwarz S, DeFelice M, von Deimling A, van Landeghem F, DiLauro R, Grüters A (2002) Choreoathetosis, hypothyroidism, and pulmonary alterations due to NKX2.1 haploinsufficiency. J Clin Invest 109:475–480
Trueba SS, Augé J, Mattei G, Etchevers H, Martinovic J, Czernichow P, Vekemans M, Polak M, Attié-Bitach T (2005) PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. J Clin Endocrinol Metab 90:455–462
Breedveld GJ, Percy AK, MacDonald ME, de Vries BBA, Yapijakis C, Dure LS, Ippel EF, Sandkuijl LA, Heutink P, Arts WFM (2002) Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 59:579–584
Kleiner-Fisman G, Rogaeva E, Halliday W, Houle S, Kawarai T, Sato C, Medeiros H, St George-Hyslop PH, Lang AE (2003) Benign hereditary chorea: clinical, genetic and pathological findings. Ann Neurol 54:244–247
Guala A, Nocita G, Di Maria E, Mandich P, Provera S, Cerruti Mainardi P, Pastore G (2001) Benign hereditary chorea: a rare cause of disability. Riv Ital Pediatr 27(Suppl):150–152
Harper PS (1978) Benign hereditary chorea. Clinical and genetic aspects. Clin Genet 13:85–95
Pohlenz J, Dumitrescu A, Zundeol D, Martiné U, Schönberger W, Koo E, Weiss RE, Cohen RN, Kimura S, Refetoff S (2002) Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 109:469–473
Willemsen MAAP, Breedveld GJ, Wouda S, Otten BJ, Yntema JL, Lammens M, de Vries BBA (2005) Brain–thyroid–lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur J Pediatr 164:28–30
Iwatani N, Mabe H, Devriendt K, Kodama M, Miike T (2000) Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr 137:272–276
Doyle DA, Gonzalez I, Thomas B, Scavina M (2004) Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2.1. J Pediatr 145:190–193
Devriendt K, Vanhole C, Matthijs G, de Zegher F (1998) Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 338:1317–1318
Asmus F, Horber V, Pohlenz J, Schwabe D, Zimprich A, Munz M, Shöning M, Gasser T (2005) A novel TITF-1 mutation causes benign hereditary chorea with response to levodopa. Neurology 64:1952–1954
Andrew SE, Goldberg YP, Theilmann J, Zeisler J, Hayden MR (1994) A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet 3:65–67
Thompson JD, Higgins DG, Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680
Hamdan H, Liu H, Li C, Jones C, Lee M, deLemos R, Minoo P (1998) Structure of the human Nkx2.1 gene. Biochim Biophys Acta 1396:336–348
Li C, Cai J, Pan Q, Minoo P (2000) Two functionally distinct forms of NKX2.1 protein are expressed in the pulmonary epithelium. Biochem Biophys Res Commun 270:462–468
Sussel L, Marin O, Kimura S, Rubenstein JLR (1999) Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development 126:3359–3370
Tsao DHH, Gruschus JM, Wang L-H, Nirenberg M, Ferretti JA (1994) Elongation of helix III of the NK-2 homeodomain upon binding to DNA: a secondary structure study by NMR. Biochemistry 33:15053–15060
Viglino P, Fogolari F, Formisano S, Bortolotti N, Damante G, Di Lauro R, Esposito G (1993) Structural study of rat thyroid transcription factor 1 homeodomain (TTF-1 HD) by nuclear magnetic resonance. FEBS Lett 336:397–402
Watada H, Mirmira RG, Kalamaras J, German MS (2000) Intramolecular control of transcriptional activity by the NK2-specific domain in NK2 homeodomain proteins. Proc Natl Acad Sci U S A 97:9443–9448
Lee HS, Gruschus JM, Zhang T, Ferretti JA (2005) NMR assignments of the DNA-bound human Csx/Nkx2.5 homeodomain and NK2-specific domain. J Biomol NMR 31:75–76
De Felice M, Damante G, Zannini M, Francis-Lang H, Di Lauro R (1995) Redundant domains contribute to the transcriptional activity of the thyroid transcription factor 1. J Biol Chem 270:26649–26656
Acknowledgements
We would like to thank the patients and family members for their collaboration and Drs. Peter Heutink and Heiko Krude for useful discussion. M.C.C. and A.F. are the recipients of Ph.D. scholarships from Fundação para a Ciência e Tecnologia, MCT, Portugal (SFRH/BD/9759/2003 and SFRH/BD/1288/2000, respectively).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
do Carmo Costa, M., Costa, C., Silva, A. et al. Nonsense mutation in TITF1 in a Portuguese family with benign hereditary chorea. Neurogenetics 6, 209–215 (2005). https://doi.org/10.1007/s10048-005-0013-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-005-0013-1